Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Uli Brödl
Person

Uli Brödl

Tracked across 3 events · 28 articles · First seen Jun 29, 2026 · Last active Jul 16, 2026

Sentiment
22
Attention
4
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
4 60
Tech
Grünenthal NOP Agonist Phase I Success
Impact: Uli Brödl, as Chief Scientific Officer at Grünenthal, expressed excitement about the successful Phase I trial, highlighting the potential of the NOP agonist to introduce a new mechanism of action in pain treatment.
Jun 29, 2026 · 9 articles
2 5
Business
Grünenthal joins CNATM
Impact: As Grünenthal's Chief Scientific Officer, Brödl announced the partnership and expressed support for the collaboration.
Jul 16, 2026 · 9 articles
2 0
Regulatory
FDA designations for Grünenthal's tegacorat
Impact: Uli Brödl, Grünenthal's Chief Scientific Officer, commented on the milestone, emphasizing the goal of addressing unmet needs in DMD treatment.
Jul 08, 2026 · 10 articles
Relationships (2)
Grünenthal chief scientific officer ↔ Uli Brödl Uli Brödl is the Chief Scientific Officer and a member of the Corporate Executiv
Grünenthal ↔ Uli Brödl
ERGEN INTELLIGENCE
Track Uli Brödl live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.